Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

10.85USD
9:00pm BST
Change (% chg)

$0.94 (+9.49%)
Prev Close
$9.91
Open
$10.05
Day's High
$11.00
Day's Low
$9.72
Volume
110,326
Avg. Vol
34,919
52-wk High
$53.14
52-wk Low
$9.53

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

Beta: --
Market Cap(Mil.): $691.72
Shares Outstanding(Mil.): 44.98
Dividend: --
Yield (%): --

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -- -- --
ROI: -- 7.52 12.69
ROE: -- 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates